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Introduction
Antimicrobial peptides (AMPs) are components of innate immune systems found in a wide variety of invertebrates and vertebrates (Beutler, 2004; Gallo and Nizet, 2003; Ganz, 2003) , and have demonstrated broad spectrum activity against bacteria, fungi, viruses, and cancer cells (Brogden et al., 2003; Hancock and Lehrer, 1998; Zasloff, 2002) . Only a few naturally-occurring instances of resistance to AMPs have been reported (Andersson and Hughes, 2010; Nizet, 2006) .
Thus, there is significant interest in developing AMPs as drugs against infectious agents since many existing antimicrobials are plagued by the emergence of resistant strains. Unfortunately, the viability of natural AMPs as therapeutics is reduced by their low structural stability and activity in physiologic environments (Chu et al., 2013; Goldman et al., 1997; Huang et al., 2011; Smith et al., 1996) and their susceptibility to proteolytic cleavage (Schmidtchen et al., 2002) .
A variety of synthetic or non-natural peptidomimetic compounds have been developed to exploit the antimicrobial properties of AMPs and to address their low stability (Godballe et al., 2011; Lienkamp et al., 2013) . One such class of compounds, β-peptides, is composed of β-amino acids and can fold into protein secondary structures found in AMPs, including the α-helix (Appella et al., 1997; , β-sheet (Chung et al., 2000; Krauthauser et al., 1997) , and γ-turn (Chung et al., 1998) . Structure-functional analyses of βpeptides have demonstrated that these compounds can be designed to exhibit antibacterial (Arvidsson et al., 2001; Epand et al., 2003; Hamuro et al., 1999; Porter et al., 2000; Raguse et al., 2002) and antifungal (Karlsson et al., 2009; Raman et al., 2015) activities at concentrations that induce little hemolysis in mammalian red blood cells. In prior work, we demonstrated that fungicidal activity of 14-helical β-peptides against the opportunistic pathogen Candida albicans requires a globally-amphiphilic structure, composed of hydrophobic and cationic faces, with approximately three helical turns (Lee et al., 2014) . We observed that both antifungal and hemolytic activities increased as β-peptides became more hydrophobic, and we identified a hydrophobicity window that resulted in high antifungal activity but low hemolysis. The addition of helix-stabilizing residues, such as aminocyclohexane carboxylic acid (ACHC), increased the activity and specificity of these 14-helical β-peptides against C. albicans.
While prior studies have shown that β-peptides and other AMP peptidomimetics have promise as antimicrobial therapeutics, little is known about their mechanism of action. The canonical mechanism of AMP-mediated toxicity involves permeabilization of the target cell membrane, a process that depends on both the physicochemical properties of the AMP and those of the target cell membrane. Several models have been proposed to describe the mechanisms of AMP permeabilization of cell membranes (Brogden, 2005; Huang, 2000; Shai, 1999; Yeaman and Yount, 2003) . In the "barrel-stave model", AMP monomers bind to the cell membrane and then oligomerize and form structured pores with the hydrophobic region of the peptide oriented toward the membrane lipids and the hydrophilic region comprising the pore channel. For example, aggregation of four to six alamethicin molecules in a cell membrane has been shown to form voltage-dependent ion channels (Boheim, 1974; Haydon, 1972, 1975) . In contrast, in the "toroidal model", peptides insert into the cell membrane and associate with lipid headgroups to induce lipid bending. Thus, the pore lining is composed of both the peptides and membrane lipids. Magainin 2 (Matsuzaki et al., 1995; Yang et al., 1998) , protegrin-1 (Lazaridis et al., 2013; Yamaguchi et al., 2002) , melittin (Yang et al., 2001; Zhou et al., 2014) , LL-37 (Lee et al., 2011) , MSI-78 (Hallock et al., 2003) , and other AMPs have been shown to act via the toroidal model. Finally, in the "carpet model", AMPs first interact with the target membrane via electrostatic interactions, and then they effectively solubilize and disrupt the membrane. Dermaceptin S (Pouny et al., 1992) , cecropin (Gazit et al., 1996) , caerin 1.1 (Pukala et al., 2004) , ovispirin (Yamaguchi et al., 2001) , and other AMPs have been suggested to follow the carpet model. Little is known about how antifungal peptidomimetic 14-helical β-peptides may induce membrane lysis and promote cell death in C. albicans.
In addition to permeabilizing the cell membrane, some AMPs act on intracellular targets to induce microbial death. Modes of intracellular action include binding nucleic acids (e.g. buforin II (Park et al., 1998) and tachyplesin (Yonezawa et al., 1992) ) and inhibiting cell-wall synthesis (mersacidin (Brotz et al., 1995) ), nucleic acid and protein synthesis (pleurocidin (Patrzykat et al., 2002) , PR-39 (Boman et al., 1993) , and HNP-1 (Lehrer et al., 1989) ), and enzymatic activity (histatins (Nishikata et al., 1991; Puri and Edgerton, 2014) , pyrrhocoricin (Gagnon et al., 2016; Otvos et al., 2000) , and drosocin (Otvos et al., 2000) ).
Prior studies have focused on interaction of AMPs with the cell membrane, but their effects on intracellular compartments, such as the nucleus, vacuole, and mitochondria have not been studied. In addition, there is little understanding of membrane disrupting mechanism of peptidomimetic β-peptides and the fates of these compounds inside the target cell. Here, we studied interactions between 14-helical β-peptides and small unilamellar vesicles (SUVs) to elicit the membrane disrupting mechanism and tracked fluorescently-labeled β-peptide to understand the interactions between peptide and intracellular organelles.
To elucidate mechanisms of β-peptide interactions with fungal cells, we first employed SUVs to investigate how membrane composition influences β-peptide adhesion to and the subsequent permeabilization of the vesicles. Next, we used confocal laser scanning microscopy (CLSM) and super resolution structure illumination microscopy (SR-SIM) to validate that cooperative binding of β-peptides observed in SUVs also occurs in C. albicans cells. Finally, time lapse microscopy tracking of fluorescently labelled β-peptides demonstrated that, after permeabilizing the cell membranes, the β-peptides lysed the nucleus and vacuole, resulting in cell death. Our results are consistent with pore-mediated mechanisms of membrane permeabilization and suggest that disruption of intracellular organelles also plays a role in the fungicidal activity of β-peptides. The improved understanding of mechanisms of β-peptide interactions with the cell membrane and organelles will enhance efforts to further develop these compounds as active and selective antifungal agents.
RESULTS

Hydrophobicity of β-peptide regulates the antifungal activity.
To study the potential mechanisms of antifungal β-peptide toxicity, we synthesized β-peptides 1 (NH2-(ACHC-β 3 hVal-β 3 hLys)3-CONH2), 2 (NH2-(ACHC-β 3 hVal-β 3 hArg)3-CONH2) and 3 (NH2-(ACHC-β 3 hAal-β 3 hLys)3-CONH2) ( Fig. 1 ). We previously demonstrated that β-peptides 1, 2, and 3 share structural properties important in antifungal activity, including charge, number of β-amino acid residues, amphiphilicity, and helical stability (Lee et al., 2014; Raman et al., 2015) . However, the hydrophobicity of these β-peptides (as determined by RP-HPLC retention time) (Browne et al., 1982; Jiang et al., 2008; Kondejewski et al., 1999; Wilson et al., 1981) , which also regulates the antifungal activity, varies substantially. The more hydrophobic β-peptides 1 and 2 exhibit an MIC against C. albicans of 8 µg/mL, while the MIC of less hydrophobic β-peptide 3 is 512 µg/mL (Table 1) . We also synthesized NBD-labeled analogues of β-peptides 1, 2, and 3 (1-NBD, 2-NBD, and 3-NBD) and Cy5-labeled β-peptide 1 (1-Cy5) ( Fig. 1 ) to facilitate quantification of β-peptide partition coefficients into synthetic lipid vesicle membranes and to visualize the interactions between the β-peptides and live C. albicans cells, respectively. After NBD-labeling of β-peptides 1, 2, and 3, peptide retention times increased, indicating that the NBD label increased the hydrophobicity of these β-peptides (Table 1, Fig. S1 ). The MICs of β-peptides 1-NBD and 2-NBD were within a factor of 2 of the MICs of the corresponding unlabeled β-peptides (Table 1, Fig. S2 ) while the MIC of 3-NBD was 8-fold lower than the MIC of β-peptide 3 (Table 1, Fig. S2 ), likely resulting from the increase in β-peptide hydrophobicity upon adding the NBD label. β-peptide 3-NBD still exhibited a 4-and 8-fold greater MIC than 1-NBD and 2-NBD, respectively. To characterize mechanisms of antifungal β-peptide toxicity, we investigated biophysical interactions of fluorescently-labelled β-peptides with model phospholipid membranes and C. albicans cell membranes, as well as the subsequent localization of β-peptides to intracellular compartments.
Permeabilization of synthetic vesicles by β-peptides depends upon membrane composition
We used the leakage of calcein from synthetic small unilamellar vesicles (SUVs) to assess the specificity of β-peptide disruption of phospholipid membranes composed of phosphatidylglycerol (PG, anionic phospholipid), phosphatidylcholine (PC, neutral phospholipid), and phosphatidylethanolamine (PE, neutral phospholipid). We prepared SUVs having different ratios of these phospholipids including PC:PE (60:40), PC:PE (80:20) as a model for fungal cell membranes (Warschawski et al., 2011) , and PC:PG (60:40) as a model for a bacterial membrane (Tamba and Yamazaki, 2005) . After preparation, the SUV size and phospholipid ratio were quantified using dynamic light scattering and 31 P nuclear magnetic resonance (Table S1 ).
Magainin 2, a pore-forming antibacterial peptide, and melittin, a pore-forming non-selective AMP, were used as controls for membrane lysis. Magainin 2 induced substantial calcein leakage only from the model bacterial membrane vesicles (PC:PG 60:40) ( Fig. 2 , and S3-5). In contrast, melittin induced calcein leakage from all SUVs tested ( Fig. 2 , and S3-5), as expected given its broad activity against bacterial, fungal, and mammalian cells. The phospholipid selectivities of magainin 2 and melittin for SUVs are consistent with prior reports of PG selectivity of magainin 2 (Gregory et al., 2009; Wieprecht et al., 1996) and broad phospholipid targeting of melittin (Magzoub et al., 2005) against large unilamellar vesicles (LUVs).
The disruption of SUVs by 14-helical β-peptides depended on the SUV and β-peptide compositions. The active antifungal β-peptides 1 and 2 resulted in about 10-20% calcein leakage from PC:PE (60:40) SUVs and 100% calcein leakage from PC:PE (80:20) SUVs after 10 min exposure to the β-peptides at the antifungal MIC (5 µM, Table 1) ( Fig. 2, Fig. S3 -4 ). The more hydrophobic β-peptide 2 induced slightly more calcein leakage from the PC:PE (60:40) SUVs than did β-peptide 1. In contrast, the inactive β-peptide 3 resulted in less than 2% calcein leakage even after 1 hr from neutral SUVs (Fig. 2, Fig. S3 -4 ).
We also quantified calcein leakage from negatively-charged PC:PG (60:40) SUVs to investigate the effects of electrostatic interactions on phospholipid membrane permeabilization by 14-helical β-peptides. β-peptides 1 and 2 lysed PC:PG (60:40) SUVs to a substantially greater extent than β-peptide 3 at and above 5 µM ( Fig. 2c ). However, β-peptides 1 and 2 elicited similar calcein leakage in PC:PG (60:40) SUVs as PC:PE (60:40) SUVs at 10 µM. β-peptide 3 caused more than ten-fold greater calcein leakage after 1 h from PC:PG (60:40) SUVs than from PC:PE (60:40) SUVs (Fig. S5 ). The activity of hydrophobic β-peptides 1 and 2 appeared to be less sensitive to electrostatic interactions than the less hydrophobic β-peptide 3. Together, these results demonstrate that the ability of 14-helical β-peptides to lyse model microbial cell membranes correlates with their antifungal activity, and suggest a potential mechanism of antifungal activity that involves cell membrane disruption.
14-Helical β-peptides lyse SUV membranes via pore formation
To characterize mechanisms of membrane disruption and distinguish between pore-forming and carpet mechanisms, we quantified the partition coefficients of NBD-labeled β-peptides in model SUV membranes. Carpet formation is characterized by a monotonic correlation between peptide concentration and membrane binding (Rapaport and Shai, 1991) . In contrast, a hallmark of pore formation is two regimes of peptide binding to the membrane (Huang, 2000; Jackman et al., 2016) . Below the critical concentration, a low partition coefficient results from peptide interactions with the membrane surface, while above the critical concentration a higher partition coefficient results from cooperative insertion of the peptides into the membrane as pores are formed (Brogden, 2005; Huang, 2000; Shai, 1999; Yeaman and Yount, 2003) .
We measured partition coefficients of 1-NBD, 2-NBD and 3-NBD in PC:PE (60:40), PC:PG (60:40), and PC:PE:ergosterol (50:30:20) SUVs (Table 2 , and S2, and Fig. 3 , and S6 -9). Partition coefficients were obtained by plotting Xb*, the corrected molar ratio of bound peptide per total outer leaflet lipid (assumed to be 60% of the total lipid) (Michaelson et al., 1974) versus Cf, the equilibrium concentration of free peptide in solution. The partition coefficient was calculated from the slope of this curve ( Fig. 3 , and S7 -9). 1-NBD and 2-NBD, which exhibit high antifungal activity (Table 1) , demonstrated greater partition coefficients, 23.6-and 35-fold higher respectively, than the less active and more hydrophilic 3-NBD in PC:PE (60:40) SUVs (Table 2, Fig. 3 ). The partition coefficients of 1-NBD and 2-NBD varied by 2-fold or less between PC:PG SUVs, while 3-NBD exhibited a 16-fold greater partition coefficient in PC:PG SUVs than PC:PE SUVs, indicating a greater dependence of partition coefficient on electrostatic interactions for 3-NBD (Table 2, Fig.   3 ). As anticipated, the partition coefficients for NBD-labeled β-peptides correlated with the extent of calcein leakage caused by the unlabeled β-peptides ( Fig. 2 ). Critical concentrations of 13.7 and 17.8 nM were identified for 1-NBD and 2-NBD, respectively, for PC:PE (60:40) SUVs, but 3-NBD did not exhibit a critical concentration against PC:PE SUVs, consistent with a mechanism of pore formation by 1-NBD and 2-NBD but not 3-NBD. All three NBD-labeled β-peptides exhibited critical concentrations between 11 and 16 nM against PC:PG (60:40) SUVs, suggesting that all three NBD-labeled β-peptides formed pores in PC:PG (60:40) SUVs (Table 2) .
We also investigated the effects of ergosterol on β-peptide partition coefficients in PC:PE SUVs (Fig. 3c ). The ratio of ergosterol was adjusted to mimic that found in the C. albicans cell membrane (Warschawski et al., 2011) . The partition coefficients of all NBD-labeled β-peptides in PC: PE:ergosterol (50:30:20) were lower than in PC:PE (60:40) SUVs (Fig. 3c , Table 2 ). The membrane sterols may inhibit the β-peptide adhesion to the membrane, as previously suggested (Bennett et al., 2009; Mason et al., 2007) . These results indicate that membrane composition dictates the ability of NBD-labeled β-peptides to form pores in these model SUVs.
14-Helical β-peptides are cooperatively inserted into the plasma membrane of C. albicans
The calcein leakage and partition coefficient experiments suggest that antifungal β-peptides permeate synthetic phospholipid membranes by binding to and forming pores in the membranes.
To explore mechanisms of β-peptide permeation of C. albicans cell membranes, we used confocal laser scanning microscopy (CLSM) and image analysis to measure relative binding of β-peptides to live C. albicans cells as a function of β-peptide concentration. In these experiments, the concentration of fluorescently-labeled β-peptide 1-Cy5 was fixed at 0.5 µM and unlabeled βpeptide 1 was added to vary the total β-peptide concentration from 0.5 to 7.0 µM. The cellassociated fluorescence signal was significantly greater above the MIC of β-peptide 1 (5.0 µM) than below the MIC ( Fig. 4 and Fig. S10 ), suggesting cooperative binding of the β-peptide to the C. albicans cell membrane. These results are consistent with a pore-forming mechanism of fungal cell toxicity and suggest a similar mechanism of poration of SUVs and living C. albicans cell membranes.
We next used super-resolution structure illumination microscopy (SR-SIM) to visualize βpeptide distribution on the C. albicans membranes. A sub-MIC concentration of β-peptide 1-Cy5
(2 µM) was incubated with live C. albicans for 3 min then imaged. Fig. 5 demonstrates that the βpeptides congregated into punctate structures around 300 nm diameter on the cell surface ( Fig.   5 ). This result suggests rapid adhesion and aggregation of β-peptides on the plasma membrane.
The concentrated β-peptides in these structures likely facilitated the supramolecular aggregation between β-peptide and lipids on the plasma membrane surface, which enables cooperative insertion into the plasma membrane to form pores in the C. albicans cell membrane.
14-Helical β-peptides form PI-permeable pores on live C. albicans
Figures 3-5 suggest that β-peptides form pores in model phospholipid membranes and in living C. albicans cell membranes. Next, we investigated whether these pores facilitate molecular translocation across the cell membrane and into the cytoplasm using the membrane-impermeable DNA-binding fluorescent dye propidium iodide (PI) as a tracer. We incubated C. albicans cells in sub-MIC (0-3 µM) concentrations of β-peptide 1 in the presence of 10 µg/mL PI and monitored PI accumulation inside the cell for 45 min using CLSM. At 2-3 µM β-peptide 1, some cells were lysed, indicated by high intensity PI staining (red cells in Fig. 6a and S11). Quantification of PI staining in the living cells demonstrated that as β-peptide concentration increased, the PI uptake into living cells increased throughout the incubation period (Fig. 6b) . These results suggest that β-peptides can form pores in the plasma membrane that permit molecular translocation at concentrations below the MIC.
Nuclear and vacuolar membranes are intracellular targets of 14-helical β-peptides
Because β-peptides form pores in the C. albicans membrane that mediate molecular translocation into the cytoplasm, it is possible that β-peptides could also cross the cell membrane and act on intracellular targets to promote cell death. To track β-peptide localization inside the cell, we monitored the co-localization of β-peptide 1-Cy5 with organelle-specific dyes. C. albicans cells were incubated with organelle-specific dyes, a mixture of β-peptides 1-Cy5 and 1, and PI.
Specifically, FM 4-64 was used to stain the plasma membrane, and SYTO 13 and Mitotracker Green were pre-incubated to stain the nucleus and mitochondria, respectively. MDY-64 was added after removing the β-peptide solution to stain the vacuolar membrane. Fig. 7a shows that β-peptide co-localized with FM 4-64, consistent with prior findings of β-peptide localization to the cell membrane (Walther and Wendland, 2004) . Following adhesion to the cell membrane, the βpeptide next translocated into the cytoplasm and associated with the nuclear membrane and the vacuolar membrane. Fig. 7b shows the β-peptide interacting with the nuclear membrane, while Fig. 7c shows β-peptide association with the vacuole. However, β-peptide did not interact with all intracellular membranes. For example, β-peptide did not co-localize with mitochondria ( Fig. 7d) .
These colocalization studies suggest that a mechanism involving lysis of nuclear and/or vacuolar membranes may contribute to the antifungal activity of β-peptides.
To determine whether β-peptides also lyse the nucleus and vacuole, we used CLSM to monitor the kinetics of association of β-peptide 1-Cy5 with intracellular organelles. Movie S1 shows that the β-peptides rapidly adhered to the C. albicans cell membrane. Next, the cell appeared to shrink, likely as a result of leakage of cytoplasmic contents following poration of the cell membrane. The β-peptide then translocated into the cytoplasm where it adhered to the nuclear and vacuolar membranes. The nuclear membrane was then disrupted, resulting in DNA dispersal throughout the cytoplasm and then the vacuole expanded until the vacuolar membrane disrupted. This sequence of events occurred over 15 min and was observed in all C. albicans cells examined.
Together, these results establish the plasma membrane, nuclear membrane, and vacuole membrane as targets for amphiphilic 14-helical β-peptides that exhibit antifungal activity.
DISCUSSION
The mode of action of helical antimicrobial peptides involves electrostatic interactions between a randomly-oriented amphiphilic peptide and the outer membrane of a target cell at the adhesion stage. Upon binding, AMPs adopt a stable and primarily helical secondary structure and selfassociate on the outer membrane until a threshold concentration is reached, resulting in cell membrane disruption, either by formation of structured pores or less-organized carpets (Shai, 1999; Yeaman and Yount, 2003) . Here, we demonstrate that peptidomimetic 14-helical β-peptides that display antifungal activity lyse the cell membrane by pore formation, allowing the β-peptides to translocate into the cytoplasm where they disrupt the nuclear and vacuolar membranes, resulting in cell death. First, we demonstrated that β-peptide permeabilization of SUVs depends upon SUV composition as well as β-peptide hydrophobicity. Based on prior work showing that βpeptide activity depends on hydrophobicity, charge, and helical stability, we predicted that these interactions would also influence β-peptide permeation of SUVs (Lee et al., 2014; Raman et al., 2015) . Indeed, calcein leakage from SUVs correlated with β-peptide hydrophobicity. Neutral charged PC:PE (60:40) SUVs exhibited greater calcein leakage than negatively charged PC:PG (60:40) SUVs after exposure to cationic β-peptides. Hydrophobic β-peptides 1 and 2 induced greater calcein leakage than the more hydrophilic β-peptide 3. Thus, β-peptide hydrophobicity appears have a more significant influence on the ability to disrupt neutral SUVs than anionic SUVs.
Hydrophobic β-peptide 2 induced similar calcein leakage from both neutral and negatively charged SUVs at 10 μg/mL peptide concentration, while less hydrophobic β-peptides 1 and 3 resulted in greater calcein leakage from negatively-charged SUVs than neutral SUVs.
The ability of β-peptides to permeabilize SUVs correlated with binding to the cell membrane SUV studies also demonstrated cooperative binding of antifungal 14-helical β-peptides in a manner consistent with pore formation. In the rapid accumulation stage, the β-peptides adhere to the cell membrane with a low partition coefficient. After reaching a threshold concentration, the βpeptides insert into the core of lipid bilayer and permeabilize the membrane in a cooperative manner, resulting in a higher partition coefficient (Huang, 2000; Shai, 1999) . Rapaport et al.
reported a critical concentration of 35 nM for the pore-forming pardaxin derivative (C 1 -NBD-par) against PC SUVs (Rapaport and Shai, 1991) . Gazit et al. demonstrated that two helical peptides derived from the pore-forming Bacillus thuringiensis serotype israelensis (Bti) toxin exhibited similar critical concentrations and partition coefficients to the full length Bti toxin (Gazit et al., 1994) .
The NBD-labeled 14-helical β-peptides used in this study exhibited high partition coefficients and low critical concentrations against model membranes (Table 2) .
Our live C. albicans studies also support a pore-forming mechanism. CLSM measurement of fluorescence accumulation using mixtures of β-peptides 1-Cy5 and 1 showed cooperative binding to the plasma membrane of live C. albicans near the MIC of β-peptide 1. This cooperative adhesion is likely related to a transition from the low to the high partition coefficient observed in the SUVs. Interestingly, β-peptide 1 permitted PI translocation across the cell membrane in live C. albicans at concentrations below the MIC. The intracellular concentration of PI depended on the β-peptide concentration and incubation time, but some membrane permeabilization was observed without resulting in cell death. Conversely, β-peptide concentrations above the MIC resulted in rapid entry of high concentrations of PI. Together, these synthetic SUV and live cell studies are consistent with a pore-forming mechanism of β-peptide permeabilization of the C. albicans cell membrane.
Mechanisms involving both plasma membrane permeation and intracellular targets have been
reported. For example, buforin 2 forms toroidal pores in bacterial cell membranes, then translocates into the cytoplasm and binds to DNA and RNA (Kobayashi et al., 2004; Park et al., 1998; Takeshima et al., 2003) . Once inside the cell, 14-helical β-peptides can disrupt the nuclear and vacuole membranes, as determined by time-lapse co-localization of Cy5-labeled β-peptides with organelle-specific fluorescent dyes. After translocating through the cell membrane, the βpeptides bind and permeabilize nuclear and vacuole membranes, sequentially (Movie S1). We show that β-peptide-induced disruption of cellular membranes, including the plasma membrane, nucleus, and vacuole, results in cell death. We predict that the potential of these compounds to disrupt multiple cell membranes could help impede development of resistance mechanisms involving changes in membrane composition.
Significance
Peptidomimetic AMPs have tremendous potential as antimicrobial agents. However, the mechanisisms of their activity and selectively are not well-understood, limiting efforts to design more effective peptidomimetic AMPs. Our results establish that 14-helical β-peptides disrupt artificial membranes and live C. albicans cell membranes. β-Peptides bind to membranes via hydrophobic and electrostatic interactions, and upon reaching a critical threshold concentration insert into and permeabilize the cell membrane in a cooperative manner. Once inside C. albicans cells, β-peptides bind and permeabilize nuclear and vacuolar membranes sequentially, leading to cell death. This understanding of the mechanisms of antifungal activity will facilitate design and development of AMP peptidomimetics, including 14-helical β-peptides, for antifungal applications. To measure the size of peptide aggregate, the fluorescence intensity vs diameter plot was fit to a Gaussian distribution (red line). The full width at half maximum intensity was taken to the be aggregate size. Average peptide aggregate size was calculated from 19 aggregates from 5 different cells. SD denotes standard deviation (n = 19). Panels Melittin 4 1.1 a The average value obtained from three independent analytical RP-HPLC measurements. b The median value obtained from three independent experiments with triplicate measurements in each. SD denotes standard deviation (n = 3). 1.1 ± 0.1 29.5 ± 2.8 11.2 ± 5.4 15.8 ± 2.9 11.5 ± 2.1 PC:PG :Ergosterol (50:30:20) 25.6 ± 3.6 38.9 ± 5.3 1.2 ± 0.1 None None None
Values represent means and SD denotes standard deviation (n = 3). 
Methods
• Key Resources
Contact for Reagent and Resource Sharing
Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Sean Palecek (sppalecek@wisc.edu)
Synthesis of fluorescently-labeled β-peptides
β-peptides were synthesized as previously reported by microwave-assisted protocols of solidphase peptide synthesis (Lee et al., 2014) . NDB and Cy5 labeling were performed after coupling and deprotection of the last β-amino acid. For NBD labeling, NBD-Cl (3 eq), and DIEA (6 eq) were premixed in DMF and then mixed with the β-peptide resin. After stirring overnight at room temperature, the resin was washed with DMF (5 times), CH2Cl2 (5 times), and DMF (5 times).
Prior to Cy5 labeling, β-peptides were coupled with an ethoxy-containing tether, (2-(2-(Fmocamino)ethoxy)-ethoxy)acetic acid (3 eq), and then the resin was washed with DMF (5 times), CH2Cl2 (5 times), and DMF (5 times). Cy5-NHS (2 eq), and DIEA (4 eq) were dissolved in DMF and then mixed with the β-peptide resin. After stirring overnight at room temperature, the resin was washed with DMF (5 times), CH2Cl2 (5 times) and DMF (5 times 
Measurement of Minimum Inhibitory Concentration (MIC) of Antifungal Peptides
The MICs of fluorophore-labeled β-peptides (1-NBD, 2-NBD, 3-NBD, and 1-Cy5), magainin 2, and melittin against C. albicans (SC5314) were determined in accordance with the broth microdilution assay suggested by the Clinical and Laboratory Standards Institute, including quantitative XTT cell metabolic assessment (Karlsson et al., 2009) . MIC was calculated as the minimum concentration that resulted in at least 90% decrease in cell viability. Peptides were assayed in RPMI medium containing 1% DMSO.
Preparation of Small Unilamellar Vesicles
The total phospholipid was maintained at 36 µmol to prepare calcein-encapsulating small Instruments Corporation). The effective vesicle size was measured between 50 -90 nm (Table   S1 ). To measure β-peptide partition coefficients, unilamellar vesicles were prepared as described for calcein-encapsulating vesicles. PC/PE (60:40) and PC/PG (60:40) vesicles were prepared at a 36 µmol scale in TBS buffer (4 mL). PC/PE/ergosterol (22.5/13.5/9 µmol, 50:30:20) vesicles were prepared at a 45 µmol scale in TBS buffer (9 mL). After purification, the vesicle composition and phospholipid concentration were measured by 31 P NMR and 1 H NMR and the effective size of vesicles was measured by DLS. The effective vesicle size was measured between 40 -80 nm (Table S2 ).
Calcein leakage
The desired concentrations of β-peptides (1 -3) , magainin 2, and melittin in TBS buffer were added to a 96 well plate (75 µL) with positive (2% Triton X100 in TBS buffer) and negative (TBS were analyzed for experiments repeated on at least three different days.
Partition coefficient measurement
All NBD labeled β-peptide stock solutions were prepared in DMSO (20 µM). SUV solution (792 µL) and peptide stock solution (8 µL) were mixed in a fluorescence cuvette and then reacted for 2 min before the recording fluorescence (ext. 468) spectrum from 480 -600 nm (F-4500
Fluorescence Spectrometer, Hitachi). Experiments were performed in triplicate using freshlyprepared SUVs on different days. After recording fluorescence spectra, the partition coefficients were calculated as reported previously (Pouny et al., 1992; Rapaport and Shai, 1991) . Briefly, the binding isotherms were assessed as partition equilibria using the following equation:
= where , and are the molar ratio of bound peptide per total lipid, the partition coefficient, and the equilibrium concentration of free peptide in the solution, respectively. In order to calculate , ∞ (the estimated maximum fluorescence intensity when vesicles are saturated by peptide) was calculated from the peptide titration curve. The (fraction of bound peptide) was calculated from the following equation:
where , and 0 are the fluorescence intensity of bound and unbound NBD-peptide, respectively. equations were corrected by the fraction of phospholipid accessible to the -peptide (60% of total lipid). Thus, the binding isotherm was represented as: * = * where * , and * are the molar ratio of bound peptide per 60% of total lipid and the estimated surface partition constant, respectively.
Adhesion of C. albicans to glass plates for microscopy
A single colony of C. albicans (SC5314) was suspended in 5 mL YPD medium and grown overnight at 32.5 o C. The cells were collected by centrifugation (2000 rpm, 5 min) and washed with DPBS buffer. ConA (2 mg/mL in DPBS, 500 µL) was adsorbed to the glass bottomed cell culture dish for 24 h at 4 o C. After incubation, the dish was rinsed with DPBS. The C. albicans cells (10 6 -10 7 cells/mL in 400 µL) were seeded on ConA-coated plates and allowed to attach for 30 min prior to CLSM and SR-SIM microscopy.
Confocal laser scanning microscopy
C. albicans cells adhered to a glass-bottomed dish were incubated with 1-Cy5 (0.5 µM) and
varying concentrations of β-peptide 1 (0, 0.5, 1.5, 3.5, 6.5 µM) in DPBS (300 µL). After 3 min incubation, cells were imaged by CLSM (Zeiss LSM 510) with a 100x objective. The excitation and emission filter were selected, excitation filter: 633 nm and emission filter: BP 650-710 IR, respectively. Images were processed using Zeiss LSM image browser.
Super resolution structure illumination microscopy (SR-SIM)
C. albicans cells adhered to a glass-bottomed dish were incubated with 2 µM 1-Cy5 in DPBS (300 µL) for 3 min and then cells were imaged by CLSM (Zeiss LSM 780) with an alpha plan-
